Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Payoux

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2018
AMYPAD Diagnostic and Patient Management Study: Rationale and designGiovanni B Frisoni, Frederik Barkhof, Daniele Altomare, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain BiomarkersMoira Marizzoni, Clarissa Ferrari, Jorge Jovicich, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI StudyDiego Albani, Moira Marizzoni, Clarissa Ferrari, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLeonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Alzheimer'S Research & Therapy|November 11, 2025
Polygenic pathways shape white matter vulnerability to Alzheimer's disease-related pathophysiological changesMario Tranfa, Leonard Pieperhoff, Giuseppe Pontillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersLeonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's DiseaseMoira Marizzoni, Clarissa Ferrari, Ambra Macis, et al.
Neurobiology of Aging|February 8, 2020
CSF cutoffs for MCI due to AD depend on APOEε4 carrier statusMoira Marizzoni, Clarissa Ferrari, Claudio Babiloni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2020
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history studyIsadora Lopes Alves, Lyduine E Collij, Daniele Altomare, et al.
Annals of Clinical and Translational Neurology|May 17, 2024
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter MicrostructureMario Tranfa, Luigi Lorenzini, Lyduine E Collij, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2018
AMYPAD Diagnostic and Patient Management Study: Rationale and designGiovanni B Frisoni, Frederik Barkhof, Daniele Altomare, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain BiomarkersMoira Marizzoni, Clarissa Ferrari, Jorge Jovicich, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2018
Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI StudyDiego Albani, Moira Marizzoni, Clarissa Ferrari, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumLeonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Alzheimer'S Research & Therapy|November 11, 2025
Polygenic pathways shape white matter vulnerability to Alzheimer's disease-related pathophysiological changesMario Tranfa, Leonard Pieperhoff, Giuseppe Pontillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersLeonard Pieperhoff, Luigi Lorenzini, Mario Tranfa, et al.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's DiseaseMoira Marizzoni, Clarissa Ferrari, Ambra Macis, et al.
Neurobiology of Aging|February 8, 2020
CSF cutoffs for MCI due to AD depend on APOEε4 carrier statusMoira Marizzoni, Clarissa Ferrari, Claudio Babiloni, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 14, 2020
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history studyIsadora Lopes Alves, Lyduine E Collij, Daniele Altomare, et al.
Annals of Clinical and Translational Neurology|May 17, 2024
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter MicrostructureMario Tranfa, Luigi Lorenzini, Lyduine E Collij, et al.
Pageof 16